Low-Dose Digoxin Improves Cardiac Function in Patients with Heart Failure, Preserved Ejection Fraction and Atrial Fibrillation – the RATE-AF Randomized Trial
European Journal of Heart Failure · 2025
DOI: 10.1002/ejhf.70022 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Karina V Bunting und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. Hauptthemen laut MEDLINE: Digoxin, Atrial Fibrillation, Heart Failure, Stroke Volume. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Birmingham Biomedical Research Centre, National Institute for Health and Care Research, British Heart Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
To compare the effect of digoxin versus beta-blockers on left ventricular function, in patients with permanent atrial fibrillation (AF) and symptoms of heart failure within the RATE-AF randomized trial. Methods and results Blinded echocardiograms were performed at baseline and 12-month follow-up using a pre-defined imaging protocol and the index-beat approach. The change in systolic and diastolic function was assessed, stratified by left ventricular ejection fraction (LVEF). Overall, 145 patients completed follow-up, with median age 75 years (interquartile range 69–82) and 44% women. In 119 patients with baseline LVEF ≥50%, a significantly greater improvement in systolic function was noted in patients randomized to low-dose digoxin versus beta-blockers: adjusted mean difference for LVEF 2.3% (95% confidence interval [CI] 0.3–4.2; p = 0.021), s′ 1.1 cm/s (95% CI 1.0–1.2; p = 0.001) and stroke volume 6.5 ml (95% CI 0.4–12.6; p = 0.037), with no difference in global longitudinal strain (p = 0.11) or any diastolic parameters. There were no significant differences between groups for patients with LVEF 40–49% and <40%. Digoxin reduced N-terminal pro-B-type natriuretic peptide compared to beta-blockers (geometric mean difference 0.77; 95% CI 0.64–0.92; p = 0.004), improved New York Heart Association functional class (odds ratio [OR] 11.3, 95% CI 4.3–29.8; p < 0.001) and modified European Heart Rhythm Association arrhythmia symptom class (OR 4.91, 95% CI 2.36–10.23; p < 0.001), with substantially less adverse events (incident rate ratio 0.21, 95% CI 0.13–0.31; p < 0.001). There were no interactions between treatment effects and baseline LVEF for these outcomes (interaction p = 0.62, 0.49, 0.07 and 0.13, respectively).
Conclusions
Low-dose digoxin in patients with symptoms of heart failure, preserved LVEF and permanent AF leads to a significantly greater improvement in systolic function compared to treatment with beta-blockers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK.
- University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
- NIHR Birmingham Biomedical Research Centre, Birmingham, UK.
- NHS West Midlands Secure Data Environment, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
- Cardiology Clinical Academic Group Molecular & Clinical Sciences Institute, City St George's University of London, London, UK.
- Patient and Public Involvement team, Birmingham, UK.
ORCID-Profile: Karina V Bunting
Förderung
- Birmingham Biomedical Research Centre
- National Institute for Health and Care Research
- British Heart Foundation
- Medical Research Council
Zitieren
APA
Bunting, K. V., Champsi, A., Gill, S. K., Saadeh, K., Camm, A. J., Stanbury, M., Haynes, S., Townend, J. N., Steeds, R. P., Kotecha, D., & RAte control Therapy Evaluation in Permanent Atrial Fibrillation (RATE‐AF) Trial Group (2025). Low-Dose Digoxin Improves Cardiac Function in Patients with Heart Failure, Preserved Ejection Fraction and Atrial Fibrillation – the RATE-AF Randomized Trial. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.70022
Vancouver
Bunting KV, Champsi A, Gill SK, Saadeh K, Camm AJ, Stanbury M, et al. Low-Dose Digoxin Improves Cardiac Function in Patients with Heart Failure, Preserved Ejection Fraction and Atrial Fibrillation – the RATE-AF Randomized Trial. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.70022
BibTeX
@article{Bunting2025,
author = {Bunting, Karina V and Champsi, Asgher and Gill, Simrat K and Saadeh, Khalil and Camm, A John and Stanbury, Mary and Haynes, Sandra and Townend, Jonathon N and Steeds, Richard P and Kotecha, Dipak and RAte control Therapy Evaluation in Permanent Atrial Fibrillation (RATE‐AF) Trial Group, RAte control Therapy Evaluation in Permanent Atrial Fibrillation (RATE‐AF) Trial Group},
title = {Low-Dose Digoxin Improves Cardiac Function in Patients with Heart Failure, Preserved Ejection Fraction and Atrial Fibrillation – the RATE-AF Randomized Trial},
journal = {European Journal of Heart Failure},
year = {2025},
doi = {10.1002/ejhf.70022}
}
EUVIMED